We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
On May 20, we issued an updated research report on Rexnord Corporation .
In the past three months, this Zacks Rank #3 (Hold) stock has returned 6.5% compared with the industry’s growth of 2.3%.
Existing Scenario
Rexnord has been gaining from operational execution, footprint-repositioning programs and its supply-chain optimization. Also, the business diversity has been allowing the company to mitigate the weakness in one end market with strength across others. Rexnord is working diligently to improve its prospects in the hygiene market.
Also, the company believes in adding complementary businesses through acquisitions. It acquired Just Manufacturing Co. and Canada-based Hadrian Inc. in 2020. Both these assets have been integrated with Rexnord’s Water Management segment. Notably, acquired assets boosted the company’s sales by 2% in the first quarter of 2021.
In addition, it focuses on rewarding shareholders through share repurchases and dividend payouts. For instance, in the first quarter of 2021, the company paid out dividends worth $10.8 million to shareholders besides repurchasing shares worth $0.9 million.
Despite the positives, weakness in the company’s Process & Motion Control segment, mainly in the aerospace business, remains a major concern. Weakness in the aerospace market might continue to hurt Rexnord’s performance in the quarters ahead.
Moreover, geographical diversification exposed the company to headwinds arising from geopolitical issues and movements in foreign currencies. Weakness in operating conditions in one or more countries might hurt its overall performance.
A. O. Smith delivered an earnings surprise of 14.84%, on average, in the trailing four quarters.
Eaton delivered an earnings surprise of 16.78%, on average, in the trailing four quarters.
Franklin Electric delivered an earnings surprise of 25.39%, on average, in the trailing four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Rexnord (RXN) Exhibits Solid Prospects Amid Persistent Risks
On May 20, we issued an updated research report on Rexnord Corporation .
In the past three months, this Zacks Rank #3 (Hold) stock has returned 6.5% compared with the industry’s growth of 2.3%.
Existing Scenario
Rexnord has been gaining from operational execution, footprint-repositioning programs and its supply-chain optimization. Also, the business diversity has been allowing the company to mitigate the weakness in one end market with strength across others. Rexnord is working diligently to improve its prospects in the hygiene market.
Also, the company believes in adding complementary businesses through acquisitions. It acquired Just Manufacturing Co. and Canada-based Hadrian Inc. in 2020. Both these assets have been integrated with Rexnord’s Water Management segment. Notably, acquired assets boosted the company’s sales by 2% in the first quarter of 2021.
In addition, it focuses on rewarding shareholders through share repurchases and dividend payouts. For instance, in the first quarter of 2021, the company paid out dividends worth $10.8 million to shareholders besides repurchasing shares worth $0.9 million.
Despite the positives, weakness in the company’s Process & Motion Control segment, mainly in the aerospace business, remains a major concern. Weakness in the aerospace market might continue to hurt Rexnord’s performance in the quarters ahead.
Moreover, geographical diversification exposed the company to headwinds arising from geopolitical issues and movements in foreign currencies. Weakness in operating conditions in one or more countries might hurt its overall performance.
Key Picks
Some better-ranked stocks from the same space are A. O. Smith Corporation (AOS - Free Report) , Eaton Corporation, plc (ETN - Free Report) and Franklin Electric Co., Inc. (FELE - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
A. O. Smith delivered an earnings surprise of 14.84%, on average, in the trailing four quarters.
Eaton delivered an earnings surprise of 16.78%, on average, in the trailing four quarters.
Franklin Electric delivered an earnings surprise of 25.39%, on average, in the trailing four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>